메뉴 건너뛰기




Volumn 49, Issue 1, 2009, Pages 337-

Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BEZAFIBRATE; FENOFIBRATE; IMMUNOGLOBULIN M; URSODEOXYCHOLIC ACID; CHOLAGOGUE;

EID: 58949098338     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22670     Document Type: Note
Times cited : (41)

References (10)
  • 1
    • 51349157245 scopus 로고    scopus 로고
    • Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
    • Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. HEPATOLOGY 2008;48:871-877.
    • (2008) HEPATOLOGY , vol.48 , pp. 871-877
    • Corpechot, C.1    Abenavoli, L.2    Rabahi, N.3    Chretien, Y.4    Andreani, T.5    Johanet, C.6
  • 2
    • 33644854254 scopus 로고    scopus 로고
    • Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
    • Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006;130:715-720.
    • (2006) Gastroenterology , vol.130 , pp. 715-720
    • Pares, A.1    Caballeria, L.2    Rodes, J.3
  • 4
    • 33745516082 scopus 로고    scopus 로고
    • Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: A meta-analysis of randomized controlled trials
    • Shi J, Wu C, Lin Y, Chen Y-X, Zhu L, Xie W. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: A meta-analysis of randomized controlled trials. Am J Gastroenterol 2006;101: 1529-1538.
    • (2006) Am J Gastroenterol , vol.101 , pp. 1529-1538
    • Shi, J.1    Wu, C.2    Lin, Y.3    Chen, Y.-X.4    Zhu, L.5    Xie, W.6
  • 5
    • 17544379813 scopus 로고    scopus 로고
    • Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines
    • Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. HEPATOLOGY 2000;31:1005-1013.
    • (2000) HEPATOLOGY , vol.31 , pp. 1005-1013
    • Heathcote, E.J.1
  • 6
    • 43049083346 scopus 로고    scopus 로고
    • Treatment of primary biliary cirrhosis: Therapy with choleretic and immunosuppressive agents
    • Silveira MG, Lindor KD. Treatment of primary biliary cirrhosis: Therapy with choleretic and immunosuppressive agents. Clin Liver Dis 2008;12: 425-443.
    • (2008) Clin Liver Dis , vol.12 , pp. 425-443
    • Silveira, M.G.1    Lindor, K.D.2
  • 8
    • 0037821923 scopus 로고    scopus 로고
    • Bezafibrate treatment: A new medical approach for PBC patients?
    • Kanda T, Yokosuka O, Imazeki F, Saisho H. Bezafibrate treatment: A new medical approach for PBC patients? J Gastroenterol 2003;38:573-578.
    • (2003) J Gastroenterol , vol.38 , pp. 573-578
    • Kanda, T.1    Yokosuka, O.2    Imazeki, F.3    Saisho, H.4
  • 9
    • 0036678375 scopus 로고    scopus 로고
    • Fenofibrate treatment in patients with primary biliary cirrhosis
    • Ohira H, Sato Y, Ueno T, Sata M. Fenofibrate treatment in patients with primary biliary cirrhosis. Am J Gastroenterol 2002;97:2147-2149.
    • (2002) Am J Gastroenterol , vol.97 , pp. 2147-2149
    • Ohira, H.1    Sato, Y.2    Ueno, T.3    Sata, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.